Elizabeth Barrett
Algemeen Directeur bij UROGEN PHARMA LTD.
Vermogen: 5 M $ op 30-04-2024
Actieve functies van Elizabeth Barrett
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
UROGEN PHARMA LTD. | Directeur/Bestuurslid | 03-01-2019 | - |
Algemeen Directeur | 03-01-2019 | - | |
President | 03-01-2019 | - | |
SAGE THERAPEUTICS, INC. | Directeur/Bestuurslid | 23-01-2019 | - |
Independent Dir/Board Member | 23-01-2019 | - | |
ALLOGENE THERAPEUTICS, INC. | Directeur/Bestuurslid | 30-07-2021 | - |
Independent Dir/Board Member | 30-07-2021 | - | |
UroGen Pharma, Inc. | Algemeen Directeur | 01-01-2019 | - |
President | 01-01-2019 | - |
Loopbaan van Elizabeth Barrett
Eerdere bekende functies van Elizabeth Barrett
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 24-03-2009 | 01-01-2019 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Algemeen Directeur | 01-02-2018 | 01-01-2019 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01-01-2006 | 01-01-2009 |
SCIENCE 37 HOLDINGS, INC. | Directeur/Bestuurslid | 23-11-2020 | - |
Independent Dir/Board Member | 23-11-2020 | - | |
JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | - | - |
Opleiding van Elizabeth Barrett
St. Joseph's University | Masters Business Admin |
University of Louisiana at Lafayette | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 15 |
Operationeel
Corporate Officer/Principal | 4 |
Chief Executive Officer | 4 |
Director/Board Member | 4 |
Sectoraal
Health Technology | 11 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
PFIZER, INC. | Health Technology |
UROGEN PHARMA LTD. | Health Technology |
SAGE THERAPEUTICS, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
ALLOGENE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Veridex LLC
Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Health Technology |
Ortho Biotech, Inc. | |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Lifesci Acquisition II Corp.
Lifesci Acquisition II Corp. Financial ConglomeratesFinance LifeSci Acquisition II Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses for its initial business. The company was founded on December 18, 2019 and is headquartered in New York, NY. | Finance |
UroGen Pharma, Inc. | Health Technology |
- Beurs
- Insiders
- Elizabeth Barrett
- Ervaring